| Browse All

First Tracks Biotherapeutics, Inc. (TRAXV)

Healthcare | Biotechnology | San Diego, United States | NasdaqGS
22.51 USD -2.89 (-11.378%) ⇩ (April 17, 2026, 4 p.m. EDT)
After hours: 22.95 +0.44 (1.955%) ⇧ (April 17, 2026, 5:52 p.m. EDT)

Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 18, 2026, 7:08 p.m. EDT

TRAXV presents a classic post-IPO momentum play driven by high volatility rather than fundamental certainty; the stock recently rallied from a ~$19 launch to near its 52-week high of $26.8 before stalling, indicating strong speculative buying, but the complete absence of dividends, earnings history, and a forecasting model predicting 0% change over the next 45 days signals significant structural uncertainty and a lack of directional conviction for long-term holders.

None
Attribute Value
Sector Healthcare
Market Cap 782,196,416

Info Dump

Attribute Value
52 Week Change 0.18473685
Address1 10,770 Wateridge Circle
Address2 Suite 210
All Time High 26.8
All Time Low 19.0
Ask 30.33
Ask Size 1
Average Daily Volume10 Day 5,640
Average Daily Volume3 Month 5,640
Average Volume 5,640
Average Volume10Days 5,640
Bid 21.54
Bid Size 1
City San Diego
Country United States
Crypto Tradeable 0
Currency USD
Current Price 22.51
Custom Price Alert Confidence HIGH
Day High 26.2
Day Low 22.5
Display Name First Tracks Biotherapeutics
Ebitda Margins 0.0
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 22.946
Fifty Day Average Change -0.43599892
Fifty Day Average Change Percent -0.019001087
Fifty Two Week Change Percent 18.473684
Fifty Two Week High 26.8
Fifty Two Week High Change -4.289999
Fifty Two Week High Change Percent -0.16007459
Fifty Two Week Low 19.0
Fifty Two Week Low Change 3.5100002
Fifty Two Week Low Change Percent 0.18473685
Fifty Two Week Range 19.0 - 26.8
First Trade Date Milliseconds 1,775,482,200,000
Full Exchange Name NasdaqGS
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Implied Shares Outstanding 34,748,841
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,026-04-06
Language en-US
Long Business Summary First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
Long Name First Tracks Biotherapeutics, Inc.
Market us_market
Market Cap 782,196,416
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1964321808
Non Diluted Market Cap 782,196,410
Open 25.8
Operating Margins 0.0
Post Market Change 0.44000053
Post Market Change Percent 1.9546891
Post Market Price 22.95
Post Market Time 1,776,462,729
Previous Close 25.4
Price Hint 2
Profit Margins 0.0
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -2.89
Regular Market Change Percent -11.378
Regular Market Day High 26.2
Regular Market Day Low 22.5
Regular Market Day Range 22.5 - 26.2
Regular Market Open 25.8
Regular Market Previous Close 25.4
Regular Market Price 22.51
Regular Market Time 1,776,456,000
Regular Market Volume 20,877
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 34,748,841
Short Name First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
Source Interval 15
State CA
Symbol TRAXV
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 22.946
Two Hundred Day Average Change -0.43599892
Two Hundred Day Average Change Percent -0.019001087
Type Disp Equity
Volume 20,877
Zip 92,121